Lisa Tan, RNACTING CLINICAL DIRECTOR
Lisa has 20 years’ experience in clinical research and development. She started her career at Cephalon Inc., working on a Phase III study of Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis. She joined Pfizer in 1996 and held positions of increasing responsibility including Senior Clinical Research Associate, Clinical Research Manager, Clinical Scientist (Associate Director) and Director. Since 2010 Lisa has worked as an independent consultant providing clinical research leadership to large pharma and smaller biotechnology clients. Lisa joined Apellis as acting Clinical Research Director in April 2012 and has provided input into the clinical development programs for APL-1 and APL-2.
Lisa has a proven track record of successes in clinical development, clinical pharmacology and translational medicine. Her main therapeutic area expertise is respiratory medicine and she also has experience in gastroenterology, nephrology and infectious diseases. Lisa is involved in strategic clinical development planning as well as the design of individual clinical studies including methodology development, first-in-human and proof-of-concept studies. Lisa has consistently delivered on the execution of these studies and has presented clinical results at major scientific conferences and published in peer reviewed journals.